The group’s adjusted operating profit grew 48% Y/Y to £6.9mln; the vacuum segment’s performance was noteworthy, with a significant increase of 26% and 89% for revenue and operating profit respectively lifting the segment’s adjusted operating margin to 23% from 15% in 1H 2017. Such a notable profit increase was thanks to a continued operational improvement, the new earnings contribution from Oxford Cryosystems, and an increased shareholding at Bordeaux.Full report is available via Capital Network website
View full JDG profile View Profile
October 02 2018
May 10 2017
April 24 2017
March 14 2018
OptiBiotix Health Plc (LON:OPTI) focuses on managing and treating widespread, chronic medical conditions, such as obesity and high cholesterol, through the modulation of the human microbiome.